Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gary Steven Sachs, M.D.

Co-Author

This page shows the publications co-authored by Gary Sachs and Jerrold Rosenbaum.
Connection Strength

1.305
  1. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2003 Jun 01; 53(11):1028-42.
    View in: PubMed
    Score: 0.278
  2. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994 Sep; 55(9):391-3.
    View in: PubMed
    Score: 0.151
  3. Assuring that double-blind is blind. Am J Psychiatry. 2010 Mar; 167(3):250-2.
    View in: PubMed
    Score: 0.111
  4. Clonazepam vs. neuroleptics as adjuncts to lithium maintenance. Psychopharmacol Bull. 1990; 26(1):137-43.
    View in: PubMed
    Score: 0.110
  5. The prevalence and clinical correlates of anger attacks during depressive episodes in bipolar disorder. J Affect Disord. 2004 Apr; 79(1-3):291-5.
    View in: PubMed
    Score: 0.074
  6. Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression. J Psychiatr Res. 2003 May-Jun; 37(3):187-92.
    View in: PubMed
    Score: 0.069
  7. Effect of abrupt change from standard to low serum levels of lithium: a reanalysis of double-blind lithium maintenance data. Am J Psychiatry. 2002 Jul; 159(7):1155-9.
    View in: PubMed
    Score: 0.065
  8. Influence of phototherapy treatment duration for seasonal affective disorder: outcome at one vs. two weeks. Biol Psychiatry. 1995 Dec 01; 38(11):747-50.
    View in: PubMed
    Score: 0.041
  9. Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study. Biol Psychiatry. 1995 Oct 01; 38(7):422-8.
    View in: PubMed
    Score: 0.041
  10. Phototherapy for seasonal affective disorder: a blind comparison of three different schedules. Am J Psychiatry. 1994 Jul; 151(7):1081-3.
    View in: PubMed
    Score: 0.037
  11. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo. J Affect Disord. 1994 Apr; 30(4):273-81.
    View in: PubMed
    Score: 0.037
  12. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry. 1993 Oct; 150(10):1485-90.
    View in: PubMed
    Score: 0.036
  13. Personality disorders in patients with panic disorder: association with childhood anxiety disorders, early trauma, comorbidity, and chronicity. Compr Psychiatry. 1992 Mar-Apr; 33(2):78-83.
    View in: PubMed
    Score: 0.032
  14. Alcohol dependence in panic disorder patients. J Psychiatr Res. 1992 Jan; 26(1):29-38.
    View in: PubMed
    Score: 0.031
  15. Pilot outreach services to homebound agoraphobic patients. Hosp Community Psychiatry. 1991 Mar; 42(3):315-7.
    View in: PubMed
    Score: 0.030
  16. Personality and bipolar disorder: dissecting state and trait associations between mood and personality. Psychol Med. 2011 Aug; 41(8):1593-604.
    View in: PubMed
    Score: 0.029
  17. Adjunctive clonazepam for maintenance treatment of bipolar affective disorder. J Clin Psychopharmacol. 1990 Feb; 10(1):42-7.
    View in: PubMed
    Score: 0.028
  18. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacol Bull. 1987; 23(1):141-4.
    View in: PubMed
    Score: 0.022
  19. National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry. 2002 Mar; 59(3):262-70.
    View in: PubMed
    Score: 0.016
  20. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review. Ann Clin Psychiatry. 2000 Sep; 12(3):137-40.
    View in: PubMed
    Score: 0.014
  21. Childhood history of anxiety in adults with panic disorder: association with anxiety sensitivity and comorbidity. Harv Rev Psychiatry. 1994 Jan-Feb; 1(5):288-93.
    View in: PubMed
    Score: 0.009
  22. Measurement of human brain lithium in vivo by MR spectroscopy. AJNR Am J Neuroradiol. 1993 Sep-Oct; 14(5):1027-37.
    View in: PubMed
    Score: 0.009
  23. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo. J Affect Disord. 1993 May; 28(1):27-38.
    View in: PubMed
    Score: 0.009
  24. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991 Feb; 52(2):69-76.
    View in: PubMed
    Score: 0.007
  25. Longitudinal course of panic disorder: findings from the Massachusetts General Hospital Naturalistic Study. J Clin Psychiatry. 1990 Dec; 51 Suppl A:12-6.
    View in: PubMed
    Score: 0.007
  26. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989 Dec; 50(12):447-9.
    View in: PubMed
    Score: 0.007
  27. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial. J Clin Psychiatry. 1987 Oct; 48 Suppl:16-21.
    View in: PubMed
    Score: 0.006
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.